omniture
logo
Search
NEXTURN BIO INC
Media Room

Photo News

rss
RosVivo Therapeutics, Inc. signed a Material Transfer Agreement (MTA) for first-in-class diabetes treatment with Eli Lilly and Company

RosVivo Therapeutics, Inc. signed a Material Transfer Agreement (MTA) for first-in-class diabetes treatment with Eli Lilly and Company

2022-02-22 20:52 2028
Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.

Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.

2021-05-30 22:00 3200
Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA

Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA

2021-05-07 07:00 3612
The world's first-in-class miRNA therapeutics to cure diabetes by pancreatic beta cell regeneration

The world's first-in-class miRNA therapeutics to cure diabetes by pancreatic beta cell regeneration

2021-05-07 07:00 2845